Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
about
Milnacipran for pain in fibromyalgia in adultsMind and body therapy for fibromyalgiaAntipsychotics for fibromyalgiaInterventions for fatigue in peripheral neuropathySelective serotonin reuptake inhibitors for fibromyalgia syndromeCannabinoids for fibromyalgiaAquatic exercise training for fibromyalgiaAnticonvulsants for fibromyalgiaCognitive behavioural therapies for fibromyalgiaProbiotics for fibromyalgiaResistance exercise training for fibromyalgiaCannabinoids for fibromyalgiaAntipsychotics for fibromyalgia in adultsAssociation of subsyndromal and depressive symptoms with inflammatory markers among different ethnic groups: the multi-ethnic study of atherosclerosis (MESA).Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial.Resting state connectivity correlates with drug and placebo response in fibromyalgia patientsPregabalin for pain in fibromyalgia in adults.More ubiquitous effects from non-pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: a meta-analysis examining six core symptoms.Juvenile fibromyalgia: current status of research and future developments.Three-Quarters of Persons in the US Population Reporting a Clinical Diagnosis of Fibromyalgia Do Not Satisfy Fibromyalgia Criteria: The 2012 National Health Interview SurveyEffect of Milnacipran on Pain in Patients with Rheumatoid Arthritis with Widespread Pain: A Randomized Blinded Crossover Trial.Characterizing "fibrofog": Subjective appraisal, objective performance, and task-related brain activity during a working memory task.The Use of Antidepressants in the Long-Term Treatment Should not Improve the Impact of Fibromyalgia on Quality of Life.Is anxious-depression an inflammatory state?Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological TreatmentsLong-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgiaReview of pharmacological therapies in fibromyalgia syndrome.Adverse Effects of Antidepressants for Chronic Pain: A Systematic Review and Meta-analysisFibromyalgia: Treating Pain in the Juvenile Patient.Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults.Oxycodone for pain in fibromyalgia in adults.Gabapentin for fibromyalgia pain in adults.Management of Widespread Pain and Fibromyalgia.Update on Treatment Guideline in Fibromyalgia Syndrome with Focus on Pharmacology.Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia.Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.Fibromyalgia Syndrome: A Case Report on Controlled Remission of Symptoms by a Dietary Strategy.Facts and myths pertaining to fibromyalgia.Saffron () versus duloxetine for treatment of patients with fibromyalgia: A randomized double-blind clinical trial
P2860
Q24186461-C080439C-F209-4A9B-8077-6A74593EFAAFQ24186559-BA6E7F75-FCB1-41B3-B62C-3C6ED662F870Q24186761-049141D0-B994-4F30-92B2-7285E27A5879Q24187233-A0482057-7A0F-420E-873D-EA8AAEDBB932Q24187263-6A250CAB-1275-4B4C-8CEB-AC80CA6FE783Q24188267-CA730E2C-CCAE-43D2-A60D-E94DA7CB97FFQ24193076-17100075-FF58-4455-8938-73173C381765Q24197464-B4C5489D-12E5-43FE-9538-EE5AED05DA18Q24198161-E3B109BB-CED3-429A-9858-676D2992F08BQ24200363-F64E08DF-FF47-4FAC-869B-301FAFE1AAD4Q24201649-75A9CF6C-69FE-4DD9-8D13-DE07253FCCB8Q26471052-E2C2A4F2-402E-44A2-A05E-15345084A46CQ26471557-6012A8EB-3FA1-4710-B795-A0928BB4319AQ33838255-547FDE67-2D2D-4063-BDB8-60AC027B0901Q34374726-BDB17C31-1ACE-4017-A2D0-A8ABBC3962C7Q34432234-16D22F64-05E3-40EC-8C81-A3D63D5A11A9Q34541472-9372B21F-6BE5-4E67-8C07-A30BEAA661BAQ35228420-D1BC6A20-C1EE-4D2B-BB15-9AFECC1308B4Q35751360-8C013851-121D-49CD-AE79-6BAC304B42D1Q36047043-6046D5A4-5465-4A1E-A744-2EEDAA8B148CQ36421939-A36F6ED2-DF56-47DF-BE31-82648A8AFFE0Q36601482-D74E7A0B-9EE8-4CED-82F7-A0C2C37589F6Q37076446-3E803EB7-58E4-48D1-8C20-2E09F310B2F5Q37195828-96187E92-2FBC-4B6E-A5C7-334157B2A936Q37197216-80E42435-5F39-4E78-9203-1346C6B61856Q37690358-F4CAC739-8D00-485C-8381-B005260C0FC3Q37691161-764A10AE-18ED-4743-B6E8-5682B0AE2FBAQ38645616-B209BC4E-B493-4EE0-9B8A-1865528C1CD9Q38680006-39129273-7550-4E96-B63A-60EE2A9679E9Q38871845-8A0BEA29-99D9-4A81-94F5-353E39C2975DQ38943074-572EB6E9-42E4-44B2-BA81-3965DC4E0288Q39043205-682F3B8F-8275-4C0C-AE3D-9AF3C60D2A8BQ41484330-7AB9B5AC-1D74-4A18-B90D-7F095A79E2A8Q51817192-25FA85A5-8A49-4A10-967A-0A8C49C96208Q52641644-5AC6C914-AAA1-4963-8342-3A924745DB3EQ52681690-A372F385-3B41-4B69-95E0-EBFCBE5E978EQ55023050-D0DBD483-018D-4981-98B1-C0632044D77AQ55312881-FB302F3C-B866-4249-B7C4-A38F1158760DQ59136726-B8598571-22F8-4591-BCE8-A13F772AB27D
P2860
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
@ast
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
@en
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
@en-gb
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
@nl
type
label
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
@ast
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
@en
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
@en-gb
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
@nl
prefLabel
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
@ast
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
@en
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
@en-gb
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
@nl
P2860
P50
P921
P3181
P1476
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
@en
P2093
P2860
P3181
P356
10.1002/14651858.CD010292
P577
2013-01-31T00:00:00Z